TCM
RGNX icon

Tradewinds Capital Management’s Regenxbio RGNX Stock Holding History

Tradewinds Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$24 – 723
2024
Q4 		$24 Hold
3
– – ﹤0.01% 663
2024
Q3 		$32 Hold
3
– – ﹤0.01% 608
2024
Q2 		$36 Hold
3
– – ﹤0.01% 580
2024
Q1 		$64 Hold
3
– – ﹤0.01% 539
2023
Q4 		$54 Hold
3
– – ﹤0.01% 466
2023
Q3 		$50 Buy
3
+2
+200% +$36 ﹤0.01% 490
2023
Q2 		$20 Hold
1
– – ﹤0.01% 471
2023
Q1 		$19 Hold
1
– – ﹤0.01% 478
2022
Q4 		$23 Hold
1
– – ﹤0.01% 511
2022
Q3 		$0 Buy
+1
New +$30 ﹤0.01% 484

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Tradewinds Capital Management's RGNX Position: Q1 2025 in Review

Tradewinds Capital Management sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 3 shares — an estimated $24 sold.

Tradewinds Capital Management first reported a position in RGNX in Q3 2022 and held it in 10 quarters. The position peaked at $64 in Q1 2024. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Tradewinds Capital Management reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Tradewinds Capital Management sold 3 Regenxbio shares in Q1 2025, an estimated $24.
  • Tradewinds Capital Management first reported a position in Regenxbio in Q3 2022 and held it in 10 quarters.
  • Tradewinds Capital Management's Regenxbio position peaked at $64 in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Tradewinds Capital Management's 13F filing for Q1 2025, filed 25 Apr 2025.